NDC 51004-1097
Scandonest L
Mepivacaine Hydrochloride And Levonordefrin
Scandonest L is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novocol Pharmaceutical Of Canada, Inc. The primary component is Mepivacaine Hydrochloride; Levonordefrin.
| Product ID | 51004-1097_59fcd689-a6a3-4739-a982-6b41c249de7b |
| NDC | 51004-1097 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Scandonest L |
| Generic Name | Mepivacaine Hydrochloride And Levonordefrin |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2013-06-27 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA088388 |
| Labeler Name | Novocol Pharmaceutical of Canada, Inc |
| Substance Name | MEPIVACAINE HYDROCHLORIDE; LEVONORDEFRIN |
| Active Ingredient Strength | 20 mg/mL; mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |